Replimune (REPL) Enterprise Value Growth (1y) (2019 - 2026)
Replimune (REPL) Enterprise Value Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.42% |
| Dec 31, 2025 | 49.84% |
| Sep 30, 2025 | 25.09% |
| Jun 30, 2025 | 14.02% |
| Mar 31, 2025 | -15.01% |
| Dec 31, 2024 | -15.05% |
| Sep 30, 2024 | 13.02% |
| Jun 30, 2024 | 12.98% |
| Mar 31, 2024 | 27.89% |
| Dec 31, 2023 | 24.34% |
| Sep 30, 2023 | -33.60% |
| Jun 30, 2023 | -36.45% |
| Mar 31, 2023 | -59.92% |
| Dec 31, 2022 | -46.70% |
| Sep 30, 2022 | 14.68% |
| Jun 30, 2022 | 13.80% |
| Mar 31, 2022 | 17.93% |
| Dec 31, 2021 | 14.82% |
| Sep 30, 2021 | -78.12% |
| Jun 30, 2021 | -75.10% |